检索结果 - Tibes, Raoul
- Showing 1 - 20 results of 49
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 study 由 Tibes, Raoul, Borad, Mitesh J., Dutcus, Corina E., Reyderman, Larisa, Feit, Kevie, Eisen, Andrew, Verbel, David A., Von Hoff, Daniel D.
出版 2018Text -
11
-
12
Triazolo[4,5-d]pyrimidines as Validated General Control Nonderepressible 2 (GCN2) Protein Kinase Inhibitors Reduce Growth of Leukemia Cells 由 Lough, Lea, Sherman, Dan, Becerra-Flores, Manuel, Vasudevan, Deepika, Lavinda, Olga, Ni, Eric, Wang, Hong, Ryoo, Hyung Don, Tibes, Raoul, Cardozo, Timothy
出版 2018Text -
13
Corrigendum to “Triazolo[4,5-d]pyrimidines as validated general control nonderepressible 2 (GCN2) protein kinase inhibitors reduce growth of leukemia cells” [Comput. Struct. Biotec... 由 Lough, Lea, Sherman, Dan, Becerra-Flores, Manuel, Vasudevan, Deepika, Lavinda, Olga, Ni, Eric, Wang, Hong, Ryoo, Hyung Don, Tibes, Raoul, Cardozo, Timothy
出版 2020Text -
14
-
15
The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials 由 Borad, Mitesh J., Curtis, Kelly K., Babiker, Hani M., Benjamin, Martin, Tibes, Raoul, Ramanathan, Ramesh K., Wright, Karen, Dueck, Amylou C., Jameson, Gayle, Von Hoff, Daniel D.
出版 2012Text -
16
Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms 由 Mughal, Tariq I., Vannucchi, Alessandro M., Soverini, Simona, Bazeos, Alexandra, Tibes, Raoul, Saglio, Giuseppe, Abdel-Wahab, Omar, Pardanani, Animesh, Hehlmann, Rudiger, Barbui, Tiziano, Van Etten, Richard, Tefferi, Ayalew, Goldman, John M.
出版 2014Text -
17
Targeting mitochondrial structure sensitizes acute myeloid leukemia to Venetoclax treatment 由 Chen, Xufeng, Glytsou, Christina, Zhou, Hua, Narang, Sonali, Reyna, Denis E., Lopez, Andrea, Sakellaropoulos, Theodore, Gong, Yixiao, Kloetgen, Andreas, Yap, Yoon Sing, Wang, Eric, Gavathiotis, Evripidis, Tsirigos, Aristotelis, Tibes, Raoul, Aifantis, Iannis
出版 2019Text -
18
Dose–response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin 由 Lorza, Andres M. Arias, Ravi, Harshan, Philip, Rohit C., Galons, Jean-Philippe, Trouard, Theodore P., Parra, Nestor A., Von Hoff, Daniel D., Read, William L., Tibes, Raoul, Korn, Ronald L., Raghunand, Natarajan
出版 2020Text -
19
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML) 由 Ravandi, Farhad, Gojo, Ivana, Patnaik, Mrinal M., Minden, Mark D., Kantarjian, Hagop, Johnson-Levonas, Amy O., Fancourt, Craig, Lam, Raymond, Jones, Mary Beth, Knox, Clayton D., Rose, Shelonitda, Patel, Payal Shah, Tibes, Raoul
出版 2016Text -
20
(68)Ga-Pentixafor PET/CT for Detection of Chemokine Receptor CXCR4 Expression in Myeloproliferative Neoplasms 由 Kraus, Sabrina, Dierks, Alexander, Rasche, Leo, Kertels, Olivia, Kircher, Malte, Schirbel, Andreas, Zovko, Josip, Steinbrunn, Torsten, Tibes, Raoul, Wester, Hans-Jürgen, Buck, Andreas K., Einsele, Hermann, Kortüm, K. Martin, Rosenwald, Andreas, Lapa, Constantin
出版 2022Text